Scopolamine Patch Withdrawal Syndrome

Abstract

Get full access to this article

View all access options for this article.

References

Transderm Scop [package insert]. Baxter Healthcare Corporation; August 2010.

Golding

, Gresty

. Motion

sickness

. Curr Opin Neurol. 2005;18:29–34.

Case studies. www.medhelp.org/posts/ear-nose-throat/scopolamine-withdrawal/show/391762. Accessed January 2008 through September 2013.

Friedman

, Jaffe

, Sharpless

. Central nervous system supersensitivity to pilocarpine after withdrawal of scopolamine. J Pharmacol Exp Ther. 1969:167(1):.45–55.

Patel

, Ezzo

. Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: Treatment with meclizine. Am J Health Syst Pharm. 2009;66(22):2024–2026.

Meclizine adult monograph. Clinical Pharmacology. http://www.clinicalpharmacology-ip.com/Forms/Monograph/monograph.aspx?cpnum=367&sec=monmech&t=0 Accessed September 15, 2013.

Saxena

, Saxena

Scopolamine withdrawal syndrome. Postgrad Med. 1990;87(1):63–66.